LCTX Operating Expenses
Lineage Cell Therapeutics, Inc. Common Stock · Operating Expenses
LCTX Operating Expenses
Latest reported$9.81Mperiod ending
LCTX Quarterly Operating Expenses ($100.00K → $9.81M)
Quarterly operating expenses
High-resolution chart · PNG
LCTX operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 9,805,000 | |
| 9,130,000 | |
| 13,090,000 | |
| 7,462,000 | |
| 22,506,000 | |
| 7,971,000 | |
| 7,824,000 | |
| 7,581,000 | |
| 7,231,000 | |
| 7,832,000 | |
| 8,019,000 | |
| 7,782,000 | |
| 8,122,000 | |
| 8,909,000 | |
| 8,452,000 | |
| 8,014,000 | |
| 8,572,000 | |
| 11,457,000 | |
| 28,994,000 | |
| 8,060,000 | |
| 7,396,000 | |
| 7,231,000 | |
| 5,934,000 | |
| 6,965,000 | |
| 6,426,000 | |
| 7,510,000 | |
| 7,581,000 | |
| 8,525,000 | |
| 10,964,000 | |
| 12,872,000 | |
| 10,226,000 | |
| 10,586,000 | |
| 9,644,000 | |
| 11,653,000 | |
| 10,078,000 | |
| 9,924,000 | |
| 10,694,000 | |
| 11,584,000 | |
| 12,031,000 | |
| 9,887,000 | |
| 14,814,000 | |
| 24,119,000 | |
| 22,105,000 | |
| 17,512,000 | |
| 13,808,000 | |
| 13,803,471 | |
| 14,625,823 | |
| 12,450,211 | |
| 13,277,075 | |
| 11,496,905 | |
| 12,872,637 | |
| 10,548,906 | |
| 8,458,485 | |
| 8,721,307 | |
| 7,416,144 | |
| 6,780,375 | |
| 7,029,077 | |
| 6,547,486 | |
| 7,091,367 | |
| 5,375,419 | |
| 5,736,547 | |
| 4,850,516 | |
| 5,173,949 | |
| 3,272,988 | |
| 2,995,702 | |
| 2,093,249 | |
| -984,502 | |
| 3,381,334 | |
| 1,539,740 | |
| 1,207,998 | |
| 1,253,303 | |
| 1,340,784 | |
| 1,359,899 | |
| 788,090 | |
| 615,918 | |
| 386,825 | |
| 504,539 | |
| 761,330 | |
| 820,205 | |
| 606,486 | |
| 784,375 | |
| 702,813 | |
| 684,422 | |
| 644,132 | |
| 676,448 | |
| 916,609 | |
| 791,334 | |
| 586,338 | |
| 643,281 | |
| 636,198 | |
| 626,583 | |
| 467,192 | |
| 590,171 | |
| 562,304 | |
| 792,131 | |
| 403,440 | |
| 634,100 | |
| 591,978 | |
| 485,823 | |
| 970,505 |